Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 (IFM 2008)

This study has been completed.
Sponsor:
Collaborators:
Celgene Corporation
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT01206205
First received: September 17, 2010
Last updated: October 22, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)